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Conclusion: Incidence and complications of ILI was low
mong HCW. Seasonal ﬂu vaccination seems to give low pro-
ection against pandemic strain. Prophylactic oseltamivir
as associated with decreased risk of H1N1 infection.
oi:10.1016/j.ijid.2010.02.1674
8.005
emographic and epidemiological characteristics of
nﬂuenza in HIMA, San Pablo Caguas Hospital, Puerto Rico
. Collado ∗, L. Collado, C. Cortes
HIMA San Pablo Caguas Hospital, 00725, PR, USA
Background: On 24 April 2009, the World Health Organi-
ation (WHO) informed of an epidemic caused by a novel
nﬂuenza A/H1N1 originating from Mexico. On 25 May 2009,
uerto Rico conﬁrms its ﬁrst case. About a month later, 11
uly 2009, WHO declares a worldwide pandemic (phase 6),
ut not before Puerto Rico reports its ﬁrst death on 15 June
009. Nevertheless, after results of submitted specimens
ere reported from CDC, HIMA•San Pablo Caguas Hospital
eceived its ﬁrst positive conﬁrmation for inﬂuenza H1N1
rom a specimen collected on May 23, 2009. The purpose of
his presentation is to assess the emergence and character-
stics of inﬂuenza A/H1N1; speciﬁcally focused in HIMA•San
ablo Caguas Hospital. The correlation between severity
f illness and clinical outcome will be analyzed in cases
dmitted to ICU. We will also determine the distribution
mong demographical characteristics, such as age, gender,
nd locality.
pidemic curve of collected specimens (n =379) of
nﬂuenza A/H1N1 by date of symptom onset, 26 April 2009
o 14 September 2009.
Methods: Clinical specimens, oral pharyngeal and/or
lood, were collected and tested using rRT-PCR, rapid
ntigen testing, or inﬂuenza titers from April 26 2009 to
eptember 14, 2009.
Results: Inﬂuenza A, B, and both A and B viruses were
dentiﬁed in 47, 6 and 3 of the Oseltamivir-treated popu-
ation (n = 375), correspondingly. Less often associated with
aboratory-conﬁrmed cases of inﬂuenza A/H1N1, were the
ncidence of mortality in obstetrical cases. Of the 379 con-
rmed and probable cases of inﬂuenza A/H1N1, 2.6% and
.7% were reported as deceased and pregnant, respectively.
mong the 379 clinically suspected cases for inﬂuenza H1N1,
nly 3 were conﬁrmed by RT-PCR sent to the Centers for
isease Control and Prevention in Atlanta. The median age
or the 79 conﬁrmed cases for inﬂuenza A and/or B was 18
ears (range, 6 month to 65 years) with a female prevalence
o
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f 63%. Complicated cases of probable and/or conﬁrmed
nﬂuenza A/H1N1 were admitted to the intensive care unit
f which 5 patients (6%) died.
eported cases of Inﬂuenza-like illness tested with RT-
CR (n=119)
Conclusion: This was an observational study demon-
trating demographic and epidemiological information of
nﬂuenza in HIMA•San Pablo Caguas Hospital.
oi:10.1016/j.ijid.2010.02.1675
8.006
nﬂuenza disease burden study on 2 sentinel sites of Mon-
olia, 2008/09 season
. Nukiwa1,∗, A. Burmaa2, T. Naranzul2, T. Kamigaki1, B.
armaa2, B. Gantsooj2, H. Oshitani1, P. Nymadawa2
Tohoku University Graduate School of Medicine, Sendai,
apan
National Inﬂuenza Center, National Center of Communica-
le Diseases, Ulaanbaatar, Mongolia
Background: Inﬂuenza may pose a large public health
ssue besides of ongoing pandemic (H1N1) 2009 in Mongo-
ia. However detailed burden of seasonal inﬂuenza remains
nknown. Here we conducted an active surveillance during
008/09 inﬂuenza season in Mongolia.
Methods: Active data and sample collection was per-
ormed in both Baganuur District, Ulaanbaatar City and
elenge Province during October 2008 to April 2009. Cases of
nﬂuenza-like illness (ILI) who visited Family Group Practi-
ioners as well as territorial hospital outpatient departments
ere enrolled in this study. In addition, contact person to
ases of ILI and hospitalized cases of severe acute res-
iratory infection (sARI) were also enrolled. Laboratory
creening for inﬂuenza viruses using rt-RT-PCR has been per-
ormed in NIC/NCCD and statistical analysis was performed
n NIC/NCCD and Tohoku University, Japan.
Results: 1,102 and 686 cases of ILI were registered from
aganuur and Selenge with 82 (7.4%) and 55 (8.0%) labora-
ory conﬁrmed inﬂuenza cases respectively. Almost half of
he cases of ILI were in the age group of 0-4 while only 2%
ere in 60 year old age group. Total of 133cases were reg-
stered as contact cases, but none of them had positive for
nﬂuenza by rt-RT-PCR. Majority of them were either parents
r siblings. There were 286 sARI cases from both sentinel
ites, but no death was reported. Duration time of onset
o hospitalization was approximately 5.2 days and average
ength of hospitalization was 9.1 days. Temporal distribution
as analyzed together with laboratory conﬁrmation done.
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The weekly ILI morbidity and inﬂuenza positive samples
in selected sites
Conclusion: This active surveillance showed a certain
existence of ILI morbidity and hospitalization especially
among 0-4 age children, but there was no death observed
during this period. In addition there were some cases of ILI
seen while no inﬂuenza was detected. A multiple year study
is necessary to ﬁgure out the disease burden of inﬂuenza and
at the same time further study including etiological study
is also necessary. At the moment, this community based
information is useful to respond current pandemic (H1N1)
2009.
doi:10.1016/j.ijid.2010.02.1676
28.007
Clinical proﬁle and outcome in 100 patients admitted with
pandemic inﬂuenza in four intensive care units in Uruguay
during the winter of 2009
H. Bagnulo1,∗, A. Soca2, M. Buroni3, G. Limongi4, E.
Echavarria5, S. Noveri 6, M. Godino7
1 Hospital Maciel, Montevideo, Uruguay
2 Hospital Pasteur, Montevideo, Uruguay
3 Hospital Espan˜ol, Montevideo, Uruguay
4 Asociacion Espan˜ola, Montevideo, Uruguay
5 Hospital Maciel, Montevideo, Uruguay
6 Hospital Pasteur, Montevideo, Uruguay
7 Hospital Maciel, Montevideo, Uruguay
Background: Pandemic Inﬂuenza Virus (AH1N1) has been
identiﬁed as the cause of respiratory infection worldwide,
has been linked to severe respiratory failure requiring fre-
quently ICU admissions
Methods: We describe the clinical and epidemiologic
characteristics of 100 patients(p) hospitalized at these
intensive care units with laboratory conﬁrmed (RT-PCR) or
acute febrile respiratory illness epidemiologically linked.
Results: 60p were conﬁrmed and 40 were epidemiogically
suspected cases. Mean Age: 45 yrs (± 16,8); 84%< 60yrs
Clinical proﬁle: cough (96%), dyspnea (93%), fever(90%),
bronchospasm (51%), headache (41%), myalgias(42%),
obtundness (35%)
Risk Factors: 31p had a body mass index >30; in 13% obe-
sity was the only risk factor. COPD (33%), cardiovascular
disease(19%), diabetes(16%), asthma(14%), pregnancy(10%).
White count cell in 70p was less than 10.000. 76p had less
than 1000 lynphocites, CPK wes elevated in 60p All tested
patients had elevated LDH; in 37/80 p>1000 IU, Most p (82)
showed bilateral interstitial alveolar images.
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iAcute Respiratoty Distress Sindrome was present in 60 p.
nvasive Mechanical Ventilation was instituted in 54 p. Alve-
lar recruitment maneuvers were necessary in 36 p; in 20
f which oxemia improved. When recruitment failed prone
osition was instituted: 7/12p also improved St pneumo-
iae was identiﬁed in 22 p (18 in tracheal aspirates and 4 in
lood cultures). In 84 p Oseltamivir was indicated; average
ose 150mg per day for 7 days. Pts who did not respond to
reatment or in obese the dose was increased to 450mg. Cor-
icosteroid were indicated most due to bronchospasm(61p)
he most important complications were trombosis (7p) and
eptic shock (35p).The most common cause of death (24/28)
as respiratory failure
Conclusion: The vast majority of our patients were
ounger than 60. High frequency of bronchospasm, myal-
ia and obtundness. Obesity and pregnancy, are special risk
actors. Lymphopenia, elevated LDH and CPK represent lab-
ratory ﬁndings. Both lungs are usually compromised.
These patients have high mortality linked to respiratory
efractory failure.
oi:10.1016/j.ijid.2010.02.1677
8.008
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apan
Background: The ongoing pandemic of 2009/H1N1
nﬂuenza has increased the awareness of the impact and
npredictable nature of inﬂuenza. This in turn has raised
he interest in the development of additional drugs to treat
he disease when vaccinations fall short. The patient pop-
lation of most concern are those classiﬁed as ‘‘high-risk’’
here inﬂuenza causes substantial morbidity and mortality.
his high-risk group comprises individuals with underly-
ng chronic disease. In this study, efﬁcacy and safety of
ntravenous administration of peramivir were evaluated in
